4 results on '"João Borges-Rosa"'
Search Results
2. Poster No. 106 Can we optimize d-dimer cut off value to predict pulmonary embolism in covid-19 patients?
- Author
-
Rafaela Fernandes, Joana Moura Ferreira, Ana Rita Alves, Gabriela Almeida, Vanessa Lopes, Gil Cunha, Gonçalo Costa, Eric Monteiro, Joana Guimarães, Diogo Fernandes, Ana Rita Gomes, João Borges Rosa, Gustavo Campos, Diana Campos, Carolina Loureiro, José Paulo Almeida, Sofia Martinho, Paulo Martins, and Lino Gonçalves
- Subjects
Physiology ,Physiology (medical) ,Cardiology and Cardiovascular Medicine - Abstract
Background Covid-19 is associated with an increased risk of pulmonary embolism (PE) therefore, should the cut off d-dimer value be adjusted for these patients? Material and methods Retrospective and observational study to understand if there is a d-dimer cut-off that could guide clinics to perform a thoracic computed tomography angiography (CTA) in patients with covid-19. The population was covid-19 patients admitted to covid-19 dedicated wards of a University Hospital Centre for one year. Results and conclusions 725 (52%) patients with covid-19 had a d-dimer value dosed during the first 5 days of the disease. Those, 63 (9%) did a CTA with a diagnosis of 16 (25%) PE. Gender was equally represented, median age was 70 years (ID = 3.49) and the majority (94%) survived. Thirteen (81%) patients with PE had a d-dimer value above 2500 ng/mL (OR = 9.244, 95% CI 2.248–9.837), with 7 (54%) with values over 10000 ng/mL, but in 3 (9%) it was under 1500 ng/mL. Seventy-three (63%) of patients with a d-dimer over 1500 ng/mL did not had a thoracic CTA performed. In our population PE was not a frequent outcome. The results are influenced by the low number of thoracic CTA performed because, even tough the cut-off d-dimer value used at our hospital to perform a thoracic CTA to exclude PE is 1500 ng/mL, most patients with that d-dimer value did not take the exam and so PE could not be excluded. Although in most PE cases the d-dimer value was above 2500 ng/mL, the results of our study cannot verify if that is a better cut-off value.
- Published
- 2022
3. Cardiac microcalcification burden: Global assessment in high cardiovascular risk subjects with Na[
- Author
-
João, Borges-Rosa, Manuel, Oliveira-Santos, Rodolfo, Silva, Nuno Pereira, da Silva, Antero, Abrunhosa, Miguel, Castelo-Branco, Lino, Gonçalves, and Maria João, Ferreira
- Subjects
Male ,Fluorine Radioisotopes ,Calcinosis ,Middle Aged ,Plaque, Atherosclerotic ,Cardiovascular Diseases ,Heart Disease Risk Factors ,Risk Factors ,Positron Emission Tomography Computed Tomography ,Positron-Emission Tomography ,Humans ,Sodium Fluoride ,Calcium ,Female ,Radiopharmaceuticals ,Aged - Abstract
Fluorine-18 sodium fluoride (Na[Thirty-four high CV risk individuals without previous CV events were scanned with Na[In a high CV risk group, the global cardiac microcalcification burden is related to CV risk factors, metabolic syndrome variables and cardiac fat. Cardiac GMCS is a promising risk stratification tool, combining a straightforward and objective methodology with a comprehensive analysis of both coronary and valvular microcalcification.
- Published
- 2020
4. Three-dimensional simulation for interventional cardiology procedures: Face and content validity
- Author
-
Carolina Sequeira, Manuel Oliveira-Santos, João Borges Rosa, João Silva Marques, Eduardo Oliveira Santos, Gustavo Norte, and Lino Gonçalves
- Subjects
Educação ,Revascularização ,Intervenção coronária percutânea ,Impressão 3D ,Simulação paciente-específica ,Treino em simulação ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Introduction and objectives: Three-dimensional (3D) model simulation provides the opportunity to manipulate real devices and learn intervention skills in a realistic, controlled, and safe environment. To ensure that simulators provide a realistic surrogate to real procedures they must undergo scientific validation. We aimed to evaluate the 3D-printed simulator SimulHeart® for face and content validity to demonstrate its value as a training tool in interventional cardiology (IC). Methods: Health professionals were recruited from sixteen Portuguese IC units. All participants received a 30-minute theoretical introduction, 10-minute demonstration of each task and then performed the intervention on a 3D-printed simulator (SimulHeart®). Finally, a post-training questionnaire focusing on the appearance of the simulation, simulation content, and satisfaction/self-efficacy was administered. Results: We included 56 participants: 16 “experts” (general and interventional cardiologists), 26 “novices” (cardiology residents), and 14 nurses and allied professionals. On a five-point Likert scale, the overall mean score of face validity was 4.38±0.35 and the overall mean score of content validity was 4.69±0.32. There was no statistically significant difference in the scores provided by “experts” and “novices”. Participants reported a high level of satisfaction/self-efficacy with 60.7% considering it strongly improved their skills. The majority (82.1%) “agreed” or “strongly agreed” that after the simulation they felt confident to perform the procedure on a patient. Conclusion: The 3D-printed simulator (SimulHeart®) showed excellent face and content validity. 3D simulation may play an important role in future IC training programs. Further research is required to correlate simulator performance with clinical performance in real patients. Resumo: Introdução e objetivos: A simulação de modelos tridimensionais (3D) proporciona a oportunidade de manipular dispositivos reais e aprender competências de intervenção num ambiente realista, controlado e seguro. Para garantir que os simuladores fornecem uma comparação realista, estes devem ser submetidos a validação científica. O nosso objetivo foi avaliar o simulador 3D SimulHeart® quanto à validade de aparência e conteúdo, para demonstrar o seu valor como ferramenta formativa em cardiologia de intervenção (CI). Métodos: Recrutamos profissionais de saúde de 16 unidades de CI portuguesas. Todos os participantes receberam uma introdução teórica de 30 minutos, 10 minutos de demonstração e de seguida tentaram realizar a intervenção num simulador 3D Simulheart. Por fim, foi aplicado um questionário pós-formação com foco na aparência da simulação, conteúdo da simulação e satisfação/autoeficácia. Resultados: Incluímos 56 participantes: 16 «especialistas» (cardiologistas gerais e de intervenção), 26 «novatos» (internos de cardiologia) e 14 enfermeiros e profissionais aliados. A pontuação média geral da validade de aparência foi de 4,38±0,35, e a pontuação média geral da validade de conteúdo foi de 4,69 ± 0,32, numa escala Likert de cinco pontos. Não houve diferenças estatisticamente significativas nas pontuações de «especialistas» e «novatos». Os participantes relataram um alto nível de satisfação/autoeficácia sendo que 60,7% consideraram que melhoraram fortemente as suas competências. A maioria (82,1%) «concordou» ou «concordou totalmente>» que após a simulação se sentiram confiantes para realizar o procedimento num paciente. Conclusão: O simulador 3D (SimulHeart®) apresentou excelente validade de aparência e de conteúdo. A simulação 3D pode desempenhar um papel importante nos programas formativos em cardiologia de intervenção. Mais estudos são necessários para correlacionar o desempenho no simulador com o desempenho clínico em pacientes reais.
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.